Gynecologic - Refresher 2022

Endometrial Cancer
This educational activity addresses the recent knowledge acquired in endometrial cancer mainly the indications for adjuvant RT and chemotherapy and the role of concurrent chemoradiation in high risk and locally advanced disease as well as the optimal sequencing approach when both modalities are used. In addition, the interpretation and potential impact of molecular markers is discussed given the recent publication of the European guidelines which based their recommendations on molecular markers. Last, the interpretation and optimal management of sentinel LN biopsy and isolated tumor cells findings is addressed.

Cervical Cancer
This course focus is on providing updates in the management of cervical cancer.  It will focus on the use of modern imaging and treatment techniques which are rapidly being adopted. This includes discussions of intensity modulated radiation therapy in the post-operative and definitive settings as well as how to integrate image guided adaptive brachytherapy. In addition speaker reviews updated guidelines for target and organ at risk suggested doses for definitive cervical cancer treatment.

This activity is available from May 16, 2022, through 11:59 p.m. Eastern time on May 15, 2025.

This activity was originally recorded at ASTRO’s virtual 2022 ASTRO Annual Refresher Course, March 27-27, 2022.

Target Audience

The activity is designed to meet the interests of radiation oncologists and radiation oncology residents, medical oncologists, surgeons, nurses and pathologists.

Learning Objectives

    Upon completion of this live activity, attendees should be able to do the following:

    Endometrial Cancer:

    • Determine the indications for systemic therapy and radiation therapy in non-metastatic endometrial cancer.
    • Determine the appropriate sequencing approach for adjuvant chemotherapy and radiation.
    • Explain the role of molecular markers and their potential impact on adjuvant therapy.
    • Interpret the significance and interpretation of sentinel LN biopsy and isolated tumor cells in LN.

    Cervical Cancer:

    • Describe the rationale and evidence for image guided adaptive brachytherapy.
    • Identify appropriate organ at risk dose constraints for image guided adaptive brachytherapy.
    • Discuss recommended contouring guidelines for intensity modulated pelvic radiation therapy.
    Course summary
    Available credit: 
    • 1.50 Certificate of Attendance
      This activity was designated for 1.50 AMA PRA Category 1 Credit™.
    • 1.50 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

    Course opens: 
    05/16/2022
    Course expires: 
    05/15/2025
    Cost:
    $105.00
    Rating: 
    0

    Lara Hathout, MD, FRCPC is employed by Rutgers Cancer Institute of New Jersey and has no financial relationships with a commercial interest.

    Micthell Kamrava, MD is employed by Cedars Sinai Medical Center and has no financial relationships with a commercial interest.

    The person(s) above served as the developer(s) of this activity. Additionally, the Education and CME/MOC Committees had control over the content of this activity.

    All relevant relationships have been mitigated.

    Disclosure link: 
    Committee Disclosures

    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

    ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification. 

    Available Credit

    • 1.50 Certificate of Attendance
      This activity was designated for 1.50 AMA PRA Category 1 Credit™.
    • 1.50 SA-CME

      The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing medical education for physicians.

      The American Society for Radiation Oncology (ASTRO) designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      This activity meets the American Board of Radiology's criteria for a self-assessment activity in the ABR's Maintenance of Certification program. Participation in this course in combination with the successful completion of the corresponding assessment and course evaluation adheres to the guidelines established by the ABR for 1.50 self-assessment credits.

    Price

    Cost:
    $105.00
    Please login or register to take this course.

    Course Fees:
    ASTRO members must log in to the ASTRO website to view and receive the discounted member rate.

    • Nonmember: $105
    • Member: $55

    Policies:
    No refunds, extensions, or substitutions will be made for participants, including those who for any reason, have not completed the course by the end of the qualification date. The qualification date for each course is listed in the course catalog on the ASTRO website under availability.

    Participants using ASTRO's online courses to satisfy the requirement of a Maintenance of Certification (MOC) program should verify the number, type and availability dates of any course before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased courses that do not align with their MOC requirement.

    The course and its materials will only be available on the ASTRO website for that 3 year period regardless of purchase date. At the expiration of the qualification, participants will no longer have access to the course or its materials. ASTRO reserves the right to remove a course before the end of its qualification period.

    Required Hardware/software

    One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.